Leading the latest haul is Kimberly-Clark Corp., which has agreed to buy struggling Tylenol maker Kenvue Inc. for roughly $40 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results